A controlled study of mesoridazine: an effective treatment for schizophrenia.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001772:Blood Cell Count; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D006801:Humans; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000627:therapeutic use
D010640:Phenothiazines; D010919:Placebos; D014149:Tranquilizing Agents; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase